Attention A T users. To access the menus on this page please perform the following steps.
1. Please switch auto forms mode to off.
2. Hit enter to expand a main menu option (Health, Benefits, etc).
3. To enter and activate the submenu links, hit the down arrow.
You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.
Locator
Contact
Search
Search
Menu
Ublituximab (Briumvi)
Ublituximab (Briumvi) is a medication administered by IV infusion for the treatment of relapsing forms of MS, which includes clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS. Ublituximab is a humanized monoclonal antibody that targets CD20 positive B lymphocytes which contribute to nerve damage in MS.
